Guidelines for the Management of Cholestatic Liver Diseases (2021)
- PMID: 36062287
- PMCID: PMC9396310
- DOI: 10.14218/JCTH.2022.00147
Guidelines for the Management of Cholestatic Liver Diseases (2021)
Abstract
In 2015, the Chinese Society of Hepatology and the Chinese Society of Gastroenterology issued a consensus statement on the diagnosis and management of cholestatic liver diseases. More clinical data on this topic have appeared during recent years. The Autoimmune Liver Disease Group of the Chinese Society of Hepatology organized an expert group to review recent evidence and provide an update to these previous guidelines. Herein, we provide 22 recommendations as a working reference for the management of cholestatic liver diseases by clinical practitioners.
Keywords: Cholestatic liver disease; Diagnosis; Practice guidelines; Therapeutics.
© 2022 Authors.
Conflict of interest statement
LL has been an associate editor of Journal of Clinical and Translational Hepatology since 2013. HY has been an editorial board member of Journal of Clinical and Translational Hepatology since 2021. YH has been an editorial board member of Journal of Clinical and Translational Hepatology since 2013. LW and JJ have been an executive associate editor of Journal of Clinical and Translational Hepatology since 2021. The other authors have no conflict of interests related to this publication.
Figures


Similar articles
-
[Guidelines on the management of cholestasis liver diseases (2021)].Zhonghua Gan Zang Bing Za Zhi. 2022 Mar 20;30(3):253-263. doi: 10.3760/cma.j.cn112138-20211112-00795. Zhonghua Gan Zang Bing Za Zhi. 2022. PMID: 35462480 Chinese.
-
[Guidelines on the management of cholestasis liver diseases (2021)].Zhonghua Nei Ke Za Zhi. 2021 Dec 1;60(12):1075-1087. doi: 10.3760/cma.j.cn112138-20211112-00795. Zhonghua Nei Ke Za Zhi. 2021. PMID: 34856682 Chinese.
-
[Guidelines on the diagnosis and management of primary sclerosing cholangitis (2021)].Zhonghua Gan Zang Bing Za Zhi. 2022 Feb 20;30(2):169-189. doi: 10.3760/cma.j.cn112138-20211109-00786. Zhonghua Gan Zang Bing Za Zhi. 2022. PMID: 35359068 Chinese.
-
UPDATE OF THE BRAZILIAN SOCIETY OF HEPATOLOGY RECOMMENDATIONS FOR DIAGNOSIS AND MANAGEMENT OF AUTOIMMUNE DISEASES OF THE LIVER.Arq Gastroenterol. 2019 Aug 13;56(2):232-241. doi: 10.1590/S0004-2803.201900000-43. Arq Gastroenterol. 2019. PMID: 31460591 Review.
-
Practice guidelines for the pathological diagnosis of primary liver cancer: 2015 update.World J Gastroenterol. 2016 Nov 14;22(42):9279-9287. doi: 10.3748/wjg.v22.i42.9279. World J Gastroenterol. 2016. PMID: 27895416 Free PMC article. Review.
Cited by
-
Effectiveness of oral methylprednisolone as adjuvant therapy for clinical improvement, biochemical markers, and inflammation in infants with cholestasis.Heliyon. 2024 Jul 14;10(14):e34110. doi: 10.1016/j.heliyon.2024.e34110. eCollection 2024 Jul 30. Heliyon. 2024. PMID: 39113947 Free PMC article.
-
Papaverine attenuates the progression of alpha naphthylisothiocyanate induce cholestasis in rats.Curr Res Pharmacol Drug Discov. 2024 Jan 28;6:100177. doi: 10.1016/j.crphar.2024.100177. eCollection 2024. Curr Res Pharmacol Drug Discov. 2024. PMID: 38322817 Free PMC article.
-
Progress in the Management of Patients with Cholestatic Liver Disease: Where Are We and Where Are We Going?J Clin Transl Hepatol. 2024 Jun 28;12(6):581-588. doi: 10.14218/JCTH.2023.00519. Epub 2024 May 11. J Clin Transl Hepatol. 2024. PMID: 38974958 Free PMC article. Review.
-
The zhuyu pill relieves rat cholestasis by regulating the mRNA expression of lipid and bile metabolism associated genes.Front Pharmacol. 2023 Oct 10;14:1280864. doi: 10.3389/fphar.2023.1280864. eCollection 2023. Front Pharmacol. 2023. PMID: 37881184 Free PMC article.
-
Prolonged Direct Hyperbilirubinemia Following Acute Hepatitis: When Not to Worry?J Clin Transl Hepatol. 2024 Dec 28;12(12):985-987. doi: 10.14218/JCTH.2024.00265. Epub 2024 Nov 8. J Clin Transl Hepatol. 2024. PMID: 39649028 Free PMC article. No abstract available.
References
-
- Kuntz K, Kuntz HD. Hepatology: Principles and Practice. 2nd ed. Heidelberg, Germany: Springer Medizin Verlag Heidelberg; 2006. pp. 227–242.
-
- Sherlock S, Dooley J. Disease of the liver and biliary system. 11th ed. Oxford, England: Blackwell Publishing; 2002. pp. 219–240.
LinkOut - more resources
Full Text Sources